Cavu Management, LP

10% owner at LTRN

Sold, on record
$2M
Dollars the filings state
Form 4 sales
2
Latest Nov 29, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • LTRNLantern Pharma Inc.10% owner

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale LTRNUnusual
    Nov 8, 2022 2022

    Sold 350,000 shares at $4.40 ($1.5M)

    Cavu Management, LP, 10% owner

    Sold 68.1% of holdings ($2.3M position)164,137 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale LTRNUnusual
    Nov 29, 2023 +386 days

    Sold 145,348 shares at $3.44 ($500k)

    Cavu Management, LP, 10% owner

    No 10b5-1 planSold 28.1% of holdings ($1.8M position)371,950 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (2)

Form 144 notices and Form 4 sales by Cavu Management, LP
Source
Nov 29, 2023Dec 1, 2023LTRN10% ownerForm 4 sale145,348$500k28.1%UnusualSEC
Nov 8, 2022Nov 9, 2022LTRN10% ownerForm 4 sale350,000$1.5M68.1%UnusualSEC